Clinical Trials · NCT06994338
Tirzepatide for Alcohol Use Disorder
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Southern California
- Enrollment
- 42
- Start date
- Oct 2025
- Locations
- 1 site, United States
- Primary endpoint
- Number of heavy drinking days